Nephrocare India successfully closes pre-IPO funding; ropes in marquee investors
by Prashant Kapadia/NHN
-
Banking veteran Deepak Parekh, HDFC Sec’s Bharat Shah and Macleods’ founder Rajendra Agarwal participated in the round
-
Led by the renowned nephrologist Dr. Pratim Sengupta, Nephrocare India envisions setting up 300 comprehensive kidney care clinics across the country in the next 8-10 years
-
The company plans to tap the capital markets for its growth funds
Kolkata, December 29, 2023: City-based Nephrocare India, a comprehensive renal care institution founded by renowned nephrologist Dr. Pratim Sengupta, today announced the successful closure of its pre-IPO round. Marquee investors, including Deepak Parekh (veteran banker and former chairman of HDFC Ltd), Bharat Shah (Chairman, HDFC Securities) and Rajendra Agarwal (Founder and MD of Macleods Pharmaceuticals), among others, participated in the funding round.
Founded in 2014, Nephrocare India has three kidney care clinics in West Bengal and a flagship holistic healthcare facility in Salt Lake, Kolkata. Dr. Sengupta has a personal vision of positively impacting the lives of close to one million patients suffering from chronic kidney disease by setting up 300 Nephrocare centres across the country in the next 8-10 years, replicating the already demonstrated hub and spoke strategy. Towards this goal, Nephrocare India expects to set up 22 high-end comprehensive kidney care facilities across the country by March 2026. Four centres will be opened by the end of the current fiscal year.
Kidney disease is a silent epidemic, and India is contributing the highest numbers of renal failure patients in the world. An estimated 1 out of 11 Indians are likely to be a victim of renal failure, the leading causes of which are said to be diabetes and hypertension. India, which is often referred to as the ‘Diabetes Capital of the World’, adds close to 2.5 lakh new patients every year to the pool of people requiring dialysis support due to advanced kidney failure. There are around seven crore patients suffering from various chronic kidney diseases, but only around 12,881 haemodialysis centres are capable of performing dialysis across the country. There is a massive gap between the demand and supply of kidney care units in India. Nephrocare India plans to bridge this gap by setting up holistic renal care units nationwide.
About the company: Nephrocare India is an advanced renal care institution that specialises in not only the most advanced treatment of kidney-related diseases but also cutting-edge research and innovation in the field of nephrology. Its team of experienced nephrologists and healthcare professionals, researchers, and data analysts are dedicated to providing patients with the highest quality care and treatment. Understanding the challenges of managing kidney-related diseases, the company offers holistic treatment plans tailored to meet each patient’s unique needs. Its state-of-the-art facilities are equipped with the latest technology and equipment and the latest innovative IT backup and wellness programme to ensure patients receive the best care possible.
Previous Article